PMC:7696151 / 52520-52737
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1513 | 155-178 | Chemical | denotes | Reactive Oxygen Species | MESH:D017382 |
| 1514 | 180-183 | Chemical | denotes | ROS | MESH:D017382 |
| 1515 | 201-204 | Chemical | denotes | HCQ | MESH:D006886 |
| 1540 | 26-38 | Disease | denotes | hypertension | MESH:D006973 |
| 1541 | 40-52 | Disease | denotes | renal damage | MESH:D007674 |
| 1542 | 58-75 | Disease | denotes | heart hypertrophy | MESH:D006332 |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T91 | 26-38 | Phenotype | denotes | hypertension | http://purl.obolibrary.org/obo/HP_0000822 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T336 | 0-217 | Sentence | denotes | Moreover, improvements in hypertension, renal damage, and heart hypertrophy occurred, probably due to the normalized endothelium response and reduction of Reactive Oxygen Species (ROS) attributable to HCQ intake [90]. |